Stocktoria

COMPASS Pathways plc CMPS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-18 · LEI

COMPASS Pathways plc financials (annual)

Revenue
2019202020212022202320242025
Net income
-$19.6M -$60.3M -$71.7M -$91.5M -$118.5M -$155.1M -$287.9M 2019202020212022202320242025
Free cash flow
-$18.0M -$41.5M -$68.1M -$106.0M -$97.4M -$119.2M 2019202020212022202320242025

Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019
R&D expense$118.4M$119.0M$87.5M$65.1M$44.0M$23.4M$12.6M
Operating income-$179.0M-$178.2M-$136.9M-$110.4M-$83.2M-$51.4M-$21.2M
Interest expense$2.2M$0$0
Income tax-$2.5M$1.6M$780,000$408,000$199,000$32,000$15,000
Net income-$287.9M-$155.1M-$118.5M-$91.5M-$71.7M-$60.3M-$19.6M
EPS (diluted)$-3.08$-2.30$-2.32$-2.16$-1.79$-3.55$-2.62
Operating cash flow-$157.2M-$119.2M-$97.4M-$105.5M-$67.7M-$41.4M-$17.8M
Free cash flow-$119.2M-$97.4M-$106.0M-$68.1M-$41.5M-$18.0M
Cash & equivalents$149.6M$165.1M$220.2M$143.2M$273.2M$190.3M$25.0M
Total assets$210.3M$213.7M$276.0M$197.3M$300.9M$203.5M$32.4M
Total liabilities$263.2M$59.0M$50.2M$16.0M$16.5M$6.9M$23.9M
Shareholders' equity-$52.8M$154.7M$225.7M$181.3M$284.4M$196.6M-$30.4M

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.